618070-31-8 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-METHYLPHENYL)-2-OXO-3-PYRROLIDINEC& is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its role in this industry is crucial as it aids in the production of drugs that can address a range of health conditions. 1-(3-METHYLPHENYL)-2-OXO-3-PYRROLIDINEC&'s biological activity is leveraged to create medications with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(3-METHYLPHENYL)-2-OXO-3-PYRROLIDINEC& serves as an intermediate in the development of products designed to enhance crop protection and improve agricultural yields. Its chemical properties make it suitable for incorporation into formulations that can combat pests and diseases affecting crops.
Used in Drug Development:
1-(3-METHYLPHENYL)-2-OXO-3-PYRROLIDINEC& is also utilized in the research and development of new drugs. Its biological activity suggests potential applications in medicinal chemistry, where it can be further modified or used as a basis for creating novel therapeutic agents to treat various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 618070-31-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,8,0,7 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 618070-31:
(8*6)+(7*1)+(6*8)+(5*0)+(4*7)+(3*0)+(2*3)+(1*1)=138
138 % 10 = 8
So 618070-31-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H13NO3/c1-8-3-2-4-9(7-8)13-6-5-10(11(13)14)12(15)16/h2-4,7,10H,5-6H2,1H3,(H,15,16)
618070-31-8Relevant academic research and scientific papers
INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Page/Page column 172, (2010/12/29)
This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.
